Contract V797P5661X
Pharmaceutical Specialties Inc · Department Of Veterans Affairs · May 20, 2004
Pharmaceutical Specialties Inc was awarded a federal contract by Department Of Veterans Affairs on May 20, 2004 for an undisclosed amount of work in pharmaceutical preparation manufacturing. The contract has been modified 6 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 15, 2010. If all options are exercised, the contract could reach $1.40 million.
Contract details
- PIID
- V797P5661X
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- May 20, 2004
- Latest action
- October 15, 2010
Description
FSC 65, PART I - SECION B PHARMACEUTICALS, DRUGS AND HEMATOLOGY PRODUCTS
Modification timeline
-
October 15, 2010Mod 9$0
-
September 30, 2010Mod 8$0
-
June 16, 2010Mod 7$0
-
March 16, 2010Mod 6$0
-
October 26, 2009Mod 5$0
-
May 28, 2009Mod 4FSC GROUP 65, PART I, SECTION B - DRUGS, PHARMACEUTICALS ^ HEMATOLOGY RELATED PRODUCTS$0
-
May 20, 2004Base awardPHARMACEUTICAL PRODUCTS$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract V797P5661X?
Contract V797P5661X is a federal contract awarded to Pharmaceutical Specialties Inc by Department Of Veterans Affairs on May 20, 2004 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 6 times since the base award.
Who won contract V797P5661X?
Pharmaceutical Specialties Inc won contract V797P5661X from Department Of Veterans Affairs.
How much is contract V797P5661X worth?
Contract V797P5661X has obligated $0 to date but carries a potential ceiling of $1.40 million if fully funded and all options are exercised.